{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:31:23Z","timestamp":1791102683784,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126407","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T17:47:59Z","timestamp":1728064079000},"page":"126407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Safety signal detected: Anaphylaxis after attenuated dengue vaccine (TAK-003) \u2013 Brazil, march 1, 2023-march 11, 2024"],"prefix":"10.1016","volume":"42","author":[{"given":"Jadher","family":"Percio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Dinamerica","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Mendes Abreu","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Karolina Barreto Berselli","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Capovilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Henrique Santos","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Elizabeth Brasil","family":"da N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibelle Mendes","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Brauner","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Loureiro","family":"Werneck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eder Gatti","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126407_bb0020","author":"Brazil. Ministry of Health"},{"key":"10.1016\/j.vaccine.2024.126407_bb0025","author":"Brazil. Ministry of Health"},{"issue":"15","key":"10.1016\/j.vaccine.2024.126407_bb0030","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.vaccine.2022.11.027","article-title":"Anaphylaxis: revision of the Brighton collaboration case definition","volume":"41","author":"Gold","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126407_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J [Internet]"},{"key":"10.1016\/j.vaccine.2024.126407_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s40413-016-0120-5","article-title":"International consensus (ICON): allergic reactions to vaccines","author":"Dreskin","year":"2016","journal-title":"World Allergy Organ J [Internet]"},{"key":"10.1016\/j.vaccine.2024.126407_bb0045","unstructured":"Dengue Tetravalent Vaccine (Live, Attenuated) Takeda | European Medicines Agency [Internet]. 2024, [cited 2024 Mar 13]. Available from: https:\/\/www.ema.europa.eu\/en\/opinion-medicine-use-outside-EU\/human\/dengue-tetravalent-vaccine-live-attenuated-takeda."},{"issue":"6","key":"10.1016\/j.vaccine.2024.126407_bb0050","doi-asserted-by":"crossref","DOI":"10.1542\/peds.110.6.e71","article-title":"VAERS Team. US vaccine adverse event reporting system. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States","volume":"110","author":"Pool","year":"2002","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126407_bb0055","first-page":"54","article-title":"Incid\u00eancia de anafilaxia relacionada \u00e0s vacinas do Programa Nacional de Imuniza\u00e7\u00f5es","volume":"v.8","author":"Hernandes","year":"2024","journal-title":"Arq Asma Alerg Imunol"},{"key":"10.1016\/j.vaccine.2024.126407_bb0060","author":"Brazil. Ministry of Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:41:43Z","timestamp":1741873303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24010892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":9,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24010892"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126407","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety signal detected: Anaphylaxis after attenuated dengue vaccine (TAK-003) \u2013 Brazil, march 1, 2023-march 11, 2024","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126407"}}